Fidelity Investments’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-32,054
Closed -$38.5K 5831
2023
Q4
$38.5K Buy
32,054
+17,683
+123% +$19.1K ﹤0.01% 3635
2023
Q3
$12.4K Buy
14,371
+12,544
+687% +$13.7K ﹤0.01% 4022
2023
Q2
$2.19K Sell
1,827
-347,242
-99% -$1.74M ﹤0.01% 4566
2023
Q1
$3.05M Buy
349,069
+142,400
+69% +$1.32M ﹤0.01% 2250
2022
Q4
$1.65M Sell
206,669
-171,026
-45% -$1.07M ﹤0.01% 2425
2022
Q3
$1.84M Buy
377,695
+121,808
+48% +$765K ﹤0.01% 2448
2022
Q2
$1.42M Sell
255,887
-113,484
-31% -$390K ﹤0.01% 2590
2022
Q1
$1.87M Sell
369,371
-377,029
-51% -$3.02M ﹤0.01% 2630
2021
Q4
$9.61M Sell
746,400
-53,600
-7% -$766K ﹤0.01% 2134
2021
Q3
$12M Hold
800,000
﹤0.01% 2057
2021
Q2
$12.4M Buy
+800,000
New +$14M ﹤0.01% 2020

Fidelity Investments's RAIN Position: Q1 2024 in Review

Fidelity Investments sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 32,054 shares — an estimated $38.5K sold.

Fidelity Investments first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $12.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

  • Fidelity Investments reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fidelity Investments sold 32,054 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $38.5K.
  • Fidelity Investments first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Fidelity Investments's Rain Oncology Inc. Common Stock position peaked at $12.4M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.